seasonal allergic rhinitis
Thirty-three patients with seasonal allergic rhinitis were in a double-blind,       double-dummy fashion randomized to treatments with oral zafirlukast (20 mg twice        a day), intranasal beclomethasone dipropionate (200 microg twice a day), or       placebo.
Thirty-three  @OBJECT$   @PREDICAT$   @SUBJECT$  were in a double-blind,       double-dummy fashion randomized to treatments with oral zafirlukast (20 mg twice        a day), intranasal beclomethasone dipropionate (200 microg twice a day), or       placebo.